Get started
Author

Fabienne Hollinger

Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
2015 · S G DuBois, S Allen, et al. · British Journal of Cancer · 60
PDF
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors
2016 · Kieuhoa T. Vo, Erin E. Karski, et al. · Oncotarget · 21
PDF
Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.
2020 · Kieuhoa T. Vo, Jennifer G. Michlitsch, et al. · Journal of Clinical Oncology · 8
Proteinuria in Metastatic Pheochromocytoma is Associated with an Increased Risk of Acute Respiratory Distress Syndrome, Spontaneously or After Therapy with 131I-Meta-iodobenzylguanidine (131I-MIBG)
2012 · A. Porzig, K. Matthay, et al. · Hormone and Metabolic Research · 8
The Importance Of Basal Blood Pressure
1955 · John R. Caldwell, Fabienne Hollinger · Henry Ford Hospital medical journal · 4
The Unreliability of Casual Blood Pressures as an Index to Cardiovascular—renal Disease
1958 · John R. Caldwell, F. W. Hollinger · Postgraduate Medicine · 2
Phase II study of 131I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.
2014 · Steven G. DuBois, M. Shelly Allen, et al. · Journal of Clinical Oncology · 1
Clinical and Biological Features of Response in Resistant Neuroblastoma to 131 I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era
2026 · Benjamin J. Lerman, Katherine K. Matthay, et al. · Pediatric Blood & Cancer
Works count: 8
Citation count: 104
H-index: 4
I10-index: 2
Year
Topic
Type